Targeting P-selectin enables safer and more effective nanomedicine delivery through caveolin-1-mediated endothelial transcytosis in preclinical medulloblastoma tumour models.
References
Arvanitis, C. D., Ferraro, G. B. & Jain, R. K. Nat. Rev. Cancer 20, 26–41 (2020).
Tylawsky, D. E. et al. Nat. Mater. https://doi.org/10.1038/s41563-023-01481-9 (2023).
Sheth, V., Wang, L., Bhattacharya, R., Mukherjee, P. & Wilhelm, S. Adv. Funct. Mater. 31, 2007363 (2021).
Terstappen, G. C., Meyer, A. H., Bell, R. D. & Zhang, W. D. Nat. Rev. Drug Discov. 20, 362–383 (2021).
Vestweber, D. & Blanks, J. E. Physiol. Rev. 79, 181–213 (1999).
Hallahan, D. E., Staba-Hogan, M. J., Virudachalam, S. & Kolchinsky, A. Cancer Res. 58, 5216–5220 (1998).
Shamay, Y. et al. Sci. Transl. Med. 8, 345ra87 (2016).
Donahue, N. D., Acar, H. & Wilhelm, S. Adv. Drug Del. Rev. 143, 68–96 (2019).
Sindhwani, S. et al. Nat. Mater. 19, 566–575 (2020).
Wilhelm, S. et al. Nat. Rev. Mater. 1, 16014 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Wang, L., Wilhelm, S. Exploiting endothelial transcytosis to reach into the brain. Nat. Mater. 22, 282–283 (2023). https://doi.org/10.1038/s41563-023-01487-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-023-01487-3
- Springer Nature Limited